Edward Wooten and Sarkis Oganyan, individually and on behalf of all others similarly situated v. BioLife Plasma Services L.P. and Takeda Pharmaceuticals U.S.A., Inc.

District Court, E.D. California·Decided October 22, 2025·No. 1:25-cv-00099·Unknown

Opinion

EDWARD WOOTEN and SARKIS No. 1:25-cv-00099-KES-SKO OGANYAN, individually and on behalf of all others similarly situated, Plaintiffs, ORDER GRANTING DEFENDANTS’ MOTION TO DISMISS v. Doc. 19 BIOLIFE PLASMA SERVICES L.P. and TAKEDA PHARMACEUTICALS U.S.A., Defendants.

Plaintiffs Evan Wooten and Sarkis Oganyan proceed on their first amended class action complaint (“FAC”), on behalf of themselves and others, against defendants BioLife Plasma Services L.P. (“BioLife”) and Takeda Pharmaceuticals U.S.A., Inc. (“Takeda”). Doc. 17 (“FAC”). Plaintiffs allege that, when they created accounts on BioLife’s website, third-party trackers installed by defendants, and operated by third-parties Snap and Salesforce, captured their email addresses and IP addresses without their consent, in violation of the California Invasion of Privacy Act (“CIPA”). Defendants move to dismiss the FAC pursuant to Federal Rules of Civil Procedure 12(b)(1), 12(b)(2), and 12(b)(6). Doc. 19.1 For the reasons set forth below, 1 Defendants’ motion did not initially seek to dismiss plaintiffs’ claims under Rule 12(b)(1) for lack of subject matter jurisdiction. See Doc. 19. However, following the filing of defendants’ motion, the Court granted the parties’ request to submit supplemental briefing regarding whether plaintiffs have standing under Article III to bring their claims. Docs. 24, 25. defendants’ motion is granted, and this action is dismissed without prejudice. I. Background2 Plaintiffs’ FAC alleges the following. BioLife and Takeda operate more than 200 blood plasma donation centers across the United States, serving thousands of monthly donors. FAC ¶ 32. In exchange for donations, donors receive monetary compensation. Id. A prospective donor cannot donate until they make an account by visiting BioLife’s website. Id. ¶ 33. When signing up for an account through the website, prospective donors are presented with an online form requesting that they provide their first name, last name, email address, and zip code. Id. ¶ 41. Once a user enters the information in the online form and clicks “next,” but before the user completes the account creation process, third party trackers installed by defendants intercept the user’s email address, the user’s IP address, and the fact that the user visited the website.3 Id. ¶ 42. The email address is captured in an encrypted format but is readily decodable and traceable to the individual user. Id. ¶¶ 47–55. The IP address allows the third parties to determine the device’s state, city, zip code, and approximate latitude and longitude. Id. ¶ 62. The intercepted email address and IP address together enable the third parties to link users’ identities across multiple websites and apps, through a process known as “ID bridging.” Id. ¶ 72. Through ID bridging, the third parties have the ability to “follow [users] all over the internet and feed them advertisements.” Id. ¶ 77. The collected data can also be used for research and marketing purposes for both defendants and the third parties. Id. ¶¶ 82, 86–90; 92–100. Plaintiff Wooten alleges that he created a BioLife account sometime in February 2023; plaintiff Oganyan alleges that he did so on or about January 28, 2024. Id. ¶¶ 6, 8. In creating their accounts, plaintiffs input the requested information on the online form, including their email addresses. Id. Wooten states he has continued to access his account through the website as recently as November 2024, and Oganyan states he did so as recently as February 2025. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Edward Wooten and Sarkis Oganyan, individually and on behalf of all others similarly situated v. BioLife Plasma Services L.P. and Takeda Pharmaceuticals U.S.A., Inc., (E.D. Cal. 2025).

Edward Wooten and Sarkis Oganyan, individually and on behalf of all others similarly situated v. BioLife Plasma Services L.P. and Takeda Pharmaceuticals U.S.A., Inc. (Edward Wooten and Sarkis Oganyan, individually and on behalf of all others similarly situated v. BioLife Plasma Services L.P. and Takeda Pharmaceuticals U.S.A., Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
United States v. Newell
658 F.3d 1 (First Circuit, 2011)
Johnson v. Dixon
786 F. Supp. 1 (District of Columbia, 1991)
Douglas Leite v. Crane Company
749 F.3d 1117 (Ninth Circuit, 2014)
Spokeo, Inc. v. Robins
578 U.S. 330 (Supreme Court, 2016)
Freshta Nayab v. Capital One Bank (Usa), Na
942 F.3d 480 (Ninth Circuit, 2019)
Perrin Davis v. Facebook, Inc.
956 F.3d 589 (Ninth Circuit, 2020)
TransUnion LLC v. Ramirez
594 U.S. 413 (Supreme Court, 2021)
Jeffrey Barke v. Eric Banks
25 F.4th 714 (Ninth Circuit, 2022)
San Diego County Credit Union v. Cefcu
65 F.4th 1012 (Ninth Circuit, 2023)
Nora Phillips v. U.S. Customs and Border Prot.
74 F.4th 986 (Ninth Circuit, 2023)
Mary Nabozny v. Optio Solutions LLC
84 F.4th 731 (Seventh Circuit, 2023)
Salazar v. NBA
118 F.4th 533 (Second Circuit, 2024)
Michael Salazar v. Paramount Global
133 F.4th 642 (Sixth Circuit, 2025)